​

Inactive/Delisted stock

Akili Stock (NASDAQ:AKLI)

ForecastRevenueFinancialsChart
Akili by TradingView

Previous Close

$0.43

52W Range

$0.19 - $1.25

50D Avg

$0.40

200D Avg

$0.38

Market Cap

$34.10M

Avg Vol (3M)

$2.30M

Beta

1.73

Div Yield

-

AKLI Company Profile

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

68

IPO Date

Jun 30, 2021

Website

AKLI Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 22
Product$419.00K

Fiscal year ends in Dec 23 | Currency in USD

AKLI Financial Summary

Dec 23Dec 22Dec 21
Revenue$1.68M$323.00K$538.00K
Operating Income$-64.48M$-90.68M$-60.72M
Net Income$-59.49M$-7.96M$-61.83M
EBITDA$-60.14M$-90.68M$-60.42M
Basic EPS$-0.76$-0.10$-0.79
Diluted EPS$-0.76$-0.10$-0.79

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 23Nov 12, 23 | 8:03 AM
Q2 23Aug 13, 23 | 9:27 AM
Q1 23May 11, 23 | 12:00 AM

Peer Comparison

TickerCompany
STRMStreamline Health Solutions, Inc.
ACONAclarion, Inc.
NRCNational Research Corporation
FORAForian Inc.
HSTMHealthStream, Inc.
HQYHealthEquity, Inc.
HCATHealth Catalyst, Inc.
EUDAEUDA Health Holdings Limited